Artelo Biosciences, Inc. (ARTL) stock
ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.18 (-10.71%)
Close on Nov 18, 2026Market cap $1.01MP/E –Yield –
Artelo Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Artelo Biosciences's price to book ratio was 0.3× on Nov 11, 2026, against 34.4× a year earlier. Over the last 5 years it ranged from 0.3× to 479.1×, with a median of 13.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.3× | −268.7 |
| 2025 | Jul 31, 2025 | 269.0× | +254.5 |
| 2024 | Dec 31, 2024 | 14.5× | +6.3 |
| 2023 | Dec 29, 2023 | 8.2× | −2.4 |
| 2022 | Dec 30, 2022 | 10.6× | −17.9 |
| 2021 | Dec 31, 2021 | 28.5× | −352.3 |
| 2020 | Dec 31, 2020 | 380.8× | −114.2 |
| 2019 | Oct 31, 2019 | 495.0× | – |
See a number that looks wrong?